3.4.21.78 Arthritis, Rheumatoid https://pubmed.ncbi.nlm.nih.gov/1731326/ Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. ongoing research 2 3.4.21.78 Arthritis, Rheumatoid https://pubmed.ncbi.nlm.nih.gov/1731326/ Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. unassigned - 3.4.21.78 Lymphoma https://pubmed.ncbi.nlm.nih.gov/1989498/ The enzymatic activity of human cytotoxic T-lymphocyte granzyme A and cytolysis mediated by cytotoxic T-lymphocytes are potently inhibited by a synthetic antiprotease, FUT-175. ongoing research 1 3.4.21.78 Lymphoma https://pubmed.ncbi.nlm.nih.gov/1989498/ The enzymatic activity of human cytotoxic T-lymphocyte granzyme A and cytolysis mediated by cytotoxic T-lymphocytes are potently inhibited by a synthetic antiprotease, FUT-175. unassigned - 3.4.21.78 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/2179951/ Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. causal interaction 4 3.4.21.78 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/2179951/ Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. ongoing research 2 3.4.21.78 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/2179951/ Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. unassigned - 3.4.21.78 Diabetes Mellitus, Type 1 https://pubmed.ncbi.nlm.nih.gov/2179951/ Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. causal interaction 4 3.4.21.78 Diabetes Mellitus, Type 1 https://pubmed.ncbi.nlm.nih.gov/2179951/ Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. ongoing research 2 3.4.21.78 Diabetes Mellitus, Type 1 https://pubmed.ncbi.nlm.nih.gov/2179951/ Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. unassigned -